DUBLIN--(BUSINESS WIRE)--The "Trauma Fixation Devices And Equipment Global Market Report 2020" report has been added to ResearchAndMarkets.com's offering.
The global trauma fixation devices and equipment market was valued at about $5.4 billion in 2018 and is expected to grow to $6.29 billion at a CAGR of 3.9% through 2022.
The trauma fixation devices and equipment market consists of sales of trauma fixation devices and equipment and related services. Trauma fixation devices and equipment are used in the treatment of patients suffering from physical trauma. They include internal fixation devices (plates and screws, intramedullary nails, compression hip screws, and cannulated screws) and external fixation devices (unilateral fixation, circular fixation, and hybrid fixation devices).
In 2018, North America was the largest region in the trauma fixation devices and equipment market. This region is expected to remain the largest during the next five years. The trauma fixation devices and equipment market in Asia Pacific is forecasted to register the highest CAGR during 2018-2023.
The trauma fixation devices and equipment market is driven by the increasing number of road accidents and sports injuries. According to WHO, approximately 1.35 million people die every year due to road traffic accidents. Also, around 20 to 50 million people suffer non-fatal injuries resulting in a disability. In 2017 alone, according to the National Safety Council (NSC), exercise and the use of exercise equipment led to the most injuries (526,000).
Basketball players reported 500,000 injuries, whereas bicycling sports specialists accounted to 457,000 injuries and 341,000 injuries were recorded for football players. Rapid rise in road accidents and sports injuries are expected to drive the trauma fixation devices and equipment market during the forecast period.
Increasing product recalls is one of the restraints for the trauma fixation treatment devices and equipment market. Product recall is a process of retrieving all faulty and defective products that have been sold or are available in the market. When a company recalls a product from the market, the company bears the cost of fixing the defective product and cost of replacement.
This replacement cost of large number of products can go up to multi-million dollars, restraining the growth of the company and for the whole market as well. For example, in 2019, Brainlab AG recalled its spine and trauma 3D navigation software as the display was showing inaccurate details that could result in user misinterpretation during surgeries and harm the patient.
Undertaking of strategic partnership and collaboration is the recent trend being followed by companies in the trauma fixation devices. This is due to the presence of a large number of vendors in the market, in order to maintain the market share in the competitive market and to enter into the new geographies, companies are making strategic partnerships with companies and Research Institutes.
For example, In December 2018, Medtronic in partnership with Shandong Weigao Group opened an R&D center to develop orthopedic technologies and devices for the local market which in turn helps Medtronic to expand their operations in China. Another such example, in November 2016, Stryker made a strategic partnership with Indo UK Institute of Health's (IUIH) Medicity Program. This 20-year long partnership would provide greater access to affordable primary joint replacements and other healthcare devices to patients in India.
The stringent regulations and validations coupled with lengthy approval time by the US-FDA is restricting the trauma fixation devices and equipment. The US 510(k) regulatory process mandates that the manufacturers should prove that a device is substantially equivalent to a standard/earlier approved device before approval. The trauma fixation devices needs a much longer time to prove safety and efficacy as these devices needs to be checked for innovative areas such as materials research and biodegradation. The changes in validation testing has also made the device approval or QC process quite strenuous.
In 2018, Medical Device Regulation (MDR) mandated implementation of two tests, ASTM F382 and ASTM F384 compulsory for all the trauma fixation devices in order to improve the performance and the quality of the devices. ASTM F382 is used to test the uniformity of the bone plate designs and ASTM F384 is used to compare the performance of the different angled designs.
Major players in the market are Zimmer Biomet Holding Inc., Stryker Corporation, DePuy Synthes, Medtronic Plc and Smith & Nephew.
Other Companies Mentioned
- B. Braun Melsungen AG
- Medartis Holding AG
- Arthrex Inc
- Depuy Synthes (J&J)
- Medtronic Plc
- Orthofix Holdings Inc
- Integra LifeSciences
- Wright Medical Group N.V
- Cardinal Health
- Accumed LLC
- Martin LP
- ReWalk Robotics
- Advance Orthopedic Solutions
- Bioretec Ltd
- Poriferous LLC
For more information about this report visit https://www.researchandmarkets.com/r/p99yqu